ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $24.00 Average Price Target from Analysts
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are currently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are currently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 […]
